High Tower Advisors, LLC Brainstorm Cell Therapeutics Inc. Transaction History

High Tower Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.15 - $0.4 $32 - $86	-215 Reduced 2.05%	10,250 $2,000
Q3 2023 Nov 08, 2023	BUY	$0.2 - $2.08 $2,093 - $21,767	10,465 New	10,465 $2,000
Q2 2021 Aug 06, 2021	SELL	$3.01 - $4.01 $31,653 - $42,169	-10,516 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$3.46 - $7.88 $36,385 - $82,866	10,516 New	10,516 $40,000
Q4 2019 Feb 14, 2020	SELL	$3.62 - $4.29 $37,162 - $44,041	-10,266 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$3.59 - $4.3 $1,795 - $2,150	-500 Reduced 4.64%	10,266 $41,000
Q4 2017 Feb 14, 2018	BUY	$2.96 - $4.42 $1,480 - $2,210	500 Added 4.87%	10,766 $42,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,266	10,266 $43,000

10.9M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $39.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.